Atossa Genetics
| Region | Nordamerika |
| ISIN | US04962H2094 |
| Sektor | Biotech |
| Website | http://www.atossagenetics.com/ |
Atossa Genetics is a clinical-stage pharmaceutical company focused on the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions.
| Titel | Datum |
|---|---|
| Stock Today: MISC Dips Amid Mixed Half-Year Results | vor ungefähr einem Monat |
| MISC's First Half Earnings Were Within Expectation | vor ungefähr einem Monat |
| MISC earnings outlook in 2H weighed by lower shipping rates, LNG supply delays, say analysts | vor ungefähr einem Monat |
| AEON, Ajinomoto, Allianz, Avillion, Bank Islam, Elridge Energy, FGV, Gamuda, GDB, Haily, Hextar, HLIND, Ivory Properties, Kerjaya, Magma,... | vor ungefähr einem Monat |
| MISC Group Q2 2025 profit falls to USD 97.5 mln | vor ungefähr einem Monat |
| Diese Aktien könnten Dich auch interessieren | |
|---|---|
| Atlas Cloud Enterprises (1 Artikel) | |
| Assure Holdings (1 Artikel) | |
| Aurelius (1 Artikel) | |
| Auris Medical (1 Artikel) | |
| Alle anzeigen | |